Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2026 11:03 ET | Source: Novo Nordisk A/S

Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK

Novo Nordisk's Wegovy® pill has been approved in the UK as an adjunct to a reduced-calorie diet and increased physical activity for adults
June 03, 2026 02:00 ET | Source: Novo Nordisk A/S

Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care

Novo Nordisk is launching Wegovy® pill in the UAE, the first country outside the US, to make the Wegovy® pill available to people living with obesity
June 01, 2026 09:00 ET | Source: Inspire

Inspire Launches GLP-1 Connect: A Free Community for Real Conversations About GLP-1 Therapies

Arlington, VA, June 01, 2026 (GLOBE NEWSWIRE) -- New online community brings together people navigating GLP-1 medications, diabetes, obesity, metabolic health, and related conditions to learn,...
May 28, 2026 06:58 ET | Source: Felix Health Inc.

Felix Offers Ozempic at Generic-Level Pricing as Lower-Cost GLP-1 Demand Remains Elevated Across Canada

Felix expands lower-cost GLP-1 access, offering Ozempic at generic-level pricing with free-start program and ongoing clinical support
May 22, 2026 09:09 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class

CHMP under (EMA) has adopted a positive opinion, recommending marketing authorisation of Wegovy® pill to reduce excess body weight
May 21, 2026 11:07 ET | Source: Research and Markets

Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs Market Report 2026 Featuring Major Players Novo Nordisk A/S, Eli Lilly and Company, and Pfizer - Global Forecast to 2030 and 2035

Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs Market Report 2026" has been added to ResearchAndMarkets.com's offering. The glucagon-like...
May 20, 2026 05:37 ET | Source: HiWell Absorfyx

HiWell Absorfyx Berberine with Ceylon Cinnamon: A Modern Approach to Daily Metabolic Wellness and Weight Management Support

HiWell Absorfyx launches 4-in-1 Berberine & Ceylon Cinnamon for metabolic health & weight management. Out now on Amazon.
May 13, 2026 20:21 ET | Source: JellyTide

JellyTide Claims Evaluated: The Gelatin Trick Recipe + Baking Soda Shot with Lemon for Weight Loss Using Jelly Tide Gummies

JellyTide complaints and under investigation searches explained - ACV + BHB gummies for fat metabolism and appetite control support.
May 12, 2026 07:00 ET | Source: Felix Health Inc.

Felix Health to Lower Semaglutide Pricing by Up to 65% as Lower-Cost Options Enter Canada

Felix to lower semaglutide pricing by up to 65% as generic options enter Canada, helping improve affordability for weight management patients.
May 12, 2026 04:00 ET | Source: AKAMPION

EktaH Shows ~50% Reduction in Post-GLP-1 Weight Rebound with Novel Obesity Treatment and Reports Positive Phase I Data

Novel alternative to GLP-1 drugs: Phase I data demonstrate fat mass reduction, preservation of lean mass, 80% responder rate, and no serious adverse events